Related Experiment Video

Updated: Jul 14, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Cognitive dysfunction in different stages in multiple sclerosis--presentation of 3 cases

Juergen H Faiss1

  • 1Depts. Neurology Teupitz & Luebben, Asklepios Fachkliniken Brandenburg GmbH, Buchholzer Str. 21, 15755, Teupitz, Germany. j.faiss@lk-teupitz.de

Journal of Neurology
|May 16, 2007
PubMed

Insights

Multiple sclerosis (MS) often causes cognitive dysfunction, affecting memory, attention, and executive function across all disease stages. This study highlights cognitive impairments even in early-stage MS patients.

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease impacting physical function.
  • Cognitive dysfunction is a common yet often overlooked symptom in MS patients.
  • Prevalence of cognitive impairment in MS ranges from 45% to 65%.

Observation:

  • Cognitive deficits in MS patients manifest diversely, including memory, attention, executive, and visuospatial impairments.
  • Previous research predominantly focused on later stages of MS.
  • This study observed cognitive dysfunction in early-stage MS patients.

Findings:

  • Cognitive dysfunction is present across all stages of multiple sclerosis.
  • Early-stage MS patients also exhibit cognitive impairments.
  • MRI findings vary among patients with MS-related cognitive dysfunction.

Implications:

  • Recognizing cognitive dysfunction in early MS is crucial for comprehensive patient care.
  • Further research is needed to understand the full spectrum of cognitive deficits in MS.
  • Tailored interventions may improve quality of life for MS patients experiencing cognitive challenges.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...